DPLO News and Press, Diplomat Pharmacy Inc. From 10/16/19

Below are the five companies in the Health Care Services industry with the highest forward earnings yields. Using projected earnings for the current fiscal year, the forward earnings yield is useful to compare a stock's return vs. owning a similar stock or other yield assets (e.g. bonds). Gene...

FLINT, Mich. , Oct. 2, 2019 /PRNewswire/ --  Diplomat Pharmacy, Inc. (NYSE: DPLO),  has appointed David Skomo as chief operating officer of CastiaRx following the retirement of Chris Luthin . CastiaRx, a division of Diplomat, is a pharmacy benefit manager (PBM) that helps hea...

Deutsche Bank's George Hill updates his ratings on the healthcare services space: More news on: CVS Health Corporation, Anthem, Inc., Cigna Corporation, Healthcare stocks news, , Read more ...

Diplomat Pharmacy, Inc. (DPLO) Q2 2019 Earnings Conference Call August 9, 2019 08:30 AM ET Company Participants Terri Anne Powers – Vice President of Investor Relations Brian Griffin – Chairman and Chief Executive Officer Dan Davison – Chief Financial Officer...

The following slide deck was published by Diplomat Pharmacy, Inc. in conjunction with their 2019 Q2 earnings Read more ...

Diplomat Pharmacy ( DPLO ) Q2 results : Revenues: $1,287.6M (-9.1%); Specialty segment: $1,215.8M (-1.5%); PBM segment: $90.3M (-52.1%). More news on: Diplomat Pharmacy, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...

Diplomat Pharmacy (NYSE: DPLO ): Q2 GAAP EPS of -$2.13 misses by $1.94 . More news on: Diplomat Pharmacy, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...

FLINT, Mich. , Aug. 9, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent provider of specialty pharmacy and infusion services, announced financial results for the quarter ended June 30, 2019 .  All comparisons, unless otherwise noted, are to...

FLINT, Mich. , Aug. 9, 2019 /PRNewswire/ --  Diplomat Pharmacy, Inc. (NYSE: DPLO)  today announced that its Board of Directors is reviewing strategic alternatives.  At the direction of its Board of Directors, the company is reviewing strategic alternatives focused...

Diplomat Pharmacy (NYSE: DPLO ) is scheduled to announce Q2 earnings results on Friday, August 9th, before market open. The consensus EPS Estimate is $0.07 (-58.8% Y/Y) and the consensus Revenue Estimate is $1.23B (-13.4% Y/Y). Over the last 2 years, DPLO  has beaten EPS estimates...